04 October 2017 | Stories

Leveraging innovation to fight HIV/AIDS, TB and malaria in Mozambique — a photo story

A doctor measures a young girl's head at a clinic in Maputo, Mozambique (Image: Unitaid)

Children with tuberculosis at Maputo Central Hospital will soon be able to receive the child-friendly TB treatment developed by the TB Alliance and its partners with funding from Unitaid. The new formulation is soluble, fruit-flavoured, and affordable. Before Unitaid’s investment, children around the world did not have access to appropriate TB medicine. As a result, caregivers often had to cut or crush tablets intended for adults. Imprecise dosing frequently led to continued illness.

A high-level Unitaid delegation visited Mozambique in September 2017 to see first-hand how the innovations it is funding in HIV testing, TB treatment and malaria prevention are making a difference in the lives of adults and children on the ground.

Read the full photo story

View All News

Featured News

13 December 2018

The Medicines Patent Pool and Unitaid publish intellectual property report on long-acting technologies

Read More

07 December 2018

Unitaid to support new tools for P. vivax malaria and long-acting medical technologies to fight disease

Read More

Sign Up for Unitaid Updates

  • This field is for validation purposes and should be left unchanged.